182 related articles for article (PubMed ID: 15810086)
1. Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen PM
World J Gastroenterol; 2005 Apr; 11(14):2166-70. PubMed ID: 15810086
[TBL] [Abstract][Full Text] [Related]
2. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor in colorectal cancer.
Damin DC; Rosito MA; Gus P; Roisemberg I; Bandinelli E; Schwartsmann G
Int J Colorectal Dis; 2002 Jan; 17(1):42-5. PubMed ID: 12018453
[TBL] [Abstract][Full Text] [Related]
4. Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up Study.
Garam N; Maláti É; Sinkovits G; Gombos T; Szederjesi A; Barabás L; Gráf L; Kocsis J; Prohászka Z
Thromb Haemost; 2018 Jan; 118(1):123-131. PubMed ID: 29304532
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
6. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
7. Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.
Guo R; Yang J; Liu X; Wu J; Chen Y
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374895
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma.
Marfia G; Navone SE; Fanizzi C; Tabano S; Pesenti C; Abdel Hadi L; Franzini A; Caroli M; Miozzo M; Riboni L; Rampini P; Campanella R
Cancer Med; 2016 Aug; 5(8):1783-90. PubMed ID: 27236861
[TBL] [Abstract][Full Text] [Related]
9. The structure of the von Willebrand factor is not altered in patients with colorectal carcinoma.
Weiss DR; Eiche C; Hupke C; Schellerer VS; Keller AK; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
Colorectal Dis; 2012 Dec; 14(12):1500-6. PubMed ID: 22507880
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
11. Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: do we have enough evidence?
Gil-Bazo I; Díaz-González JA; Rodríguez J; Cortés J; Calvo E; Páramo JA; García-Foncillas J
World J Gastroenterol; 2005 Oct; 11(38):6072-3. PubMed ID: 16273629
[No Abstract] [Full Text] [Related]
12. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
13. Significance of intratumoral microvessel density quantification based on immunohistochemical detection of PECAM-1 and vWF in colorectal carcinoma from Iraqi patients.
Ahmed MM; Mohammed SH
Indian J Pathol Microbiol; 2010; 53(3):439-46. PubMed ID: 20699499
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
Huang L; Fang J; Wu J; Zhou X; Wei H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
[TBL] [Abstract][Full Text] [Related]
16. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.
Stephens RW; Nielsen HJ; Christensen IJ; Thorlacius-Ussing O; Sørensen S; Danø K; Brünner N
J Natl Cancer Inst; 1999 May; 91(10):869-74. PubMed ID: 10340907
[TBL] [Abstract][Full Text] [Related]
17. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer.
Lackner C; Jukic Z; Tsybrovskyy O; Jatzko G; Wette V; Hoefler G; Klimpfinger M; Denk H; Zatloukal K
Virchows Arch; 2004 Aug; 445(2):160-7. PubMed ID: 15232739
[TBL] [Abstract][Full Text] [Related]
19. Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor.
Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
Gastric Cancer; 2002; 5(3):137-41. PubMed ID: 12378339
[TBL] [Abstract][Full Text] [Related]
20. Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer.
Gil-Bazo I; Catalán Goni V; Alonso Gutiérrez A; Rodríguez Rodríguez J; Páramo Fernández JA; de la Cámara Gómez J; Hernández Lizoain JL; García-Foncillas López J
Clin Transl Oncol; 2005 May; 7(4):150-5. PubMed ID: 15960922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
